Olmesartan/amlodipino pensa 40 mg/10 mg comprimidos recubiertos con pelicula efg

Leaflet: information for the user

Olmesartan/Amlodipine pensa 40 mg/10 mg film-coated tablets EFG

olmesartan medoxomilo / amlodipino

Read this leaflet carefully before you start taking this medicine, because it contains important information for you.

-Keep this leaflet, as you may need to read it again.

-If you have any questions, ask your doctor or pharmacist.

-This medicine has been prescribed for you only, and you must not give it to others even if they have the same symptoms as you, as it may harm them.and you must not give it to others even if they have the same symptoms as you, as it may harm them.

-If you experience any side effects, consult your doctor, or pharmacist, even if they are not listed in this leaflet. See section 4.

1. What is Olmesartan / Amlodipine Pensa and what it is used for

2. What you need to know before starting to take Olmesartan / Amlodipine Pensa

3. How to take Olmesartan / Amlodipine Pensa

4. Possible side effects

5. Storage of Olmesartan / Amlodipine Pensa

6. Contents of the pack and additional information

Olmesartan/Amlodipino Pensa contains two substances called olmesartan medoxomil and amlodipine (as amlodipine besylate). The two substances help control high blood pressure.

• Olmesartan belongs to a group of medicines called “angiotensin II receptor antagonists”, which decrease blood pressure by relaxing blood vessels.
• Amlodipine belongs to a group of medicines called “calcium channel blockers”. Amlodipine prevents calcium from entering the blood vessel wall, preventing blood vessel constriction, which also decreases blood pressure.

The action of both substances contributes to preventing blood vessel constriction, so that they relax and blood pressure decreases.

Olmesartan /Amlodipino Pensa is used to treat high blood pressure in patients whose blood pressure is not adequately controlled with olmesartan or amlodipine alone.

Do not take Olmesartan /Amlodipino Pensa

• If you are allergic to olmesartan medoxomilo, or to amlodipino, or to a group of special calcium channel blockers, called dihidropiridinas, or to any of the othercomponents of this medication (including in the section 6).

Inform your doctor before taking Olmesartan medoxomilo/Amlodipino Pensa if you think you may be allergic.

• If you are more than 3 months pregnant. It is best to avoid Olmesartan medoxomilo/Amlodipino Pensa at the beginning of pregnancy (see section “Pregnancy and breastfeeding”).
• If you have diabetes or kidney failure and are being treated with a medication to lower blood pressure that contains aliskirén.
• If you have severe liver problems, if the secretion of bile is altered, or if the release of bile by the gallbladder is blocked (for example, by gallstones), or if you have jaundice (yellow skin and eyes).
• If you have very low blood pressure.
• If you have inadequate blood flow to tissues, with symptoms such as low blood pressure, weak pulse, rapid heart rate (shock, including cardiogenic shock). Cardiogenic shock means shock due to severe heart problems.
• If the blood flow to your heart is blocked (for example, due to narrowing of the aorta (aortic stenosis)).
• If you have poor heart function (producing difficulty breathing, or peripheral edema) after a heart attack (acute myocardial infarction).

Warnings and precautions

Consult your doctor or pharmacist before starting to use Olmesartan /Amlodipino Pensa.

Tell your doctorif you are taking any of the following medications used to treat high blood pressure (hypertension):

• An angiotensin-converting enzyme inhibitor (ACE inhibitor) (for example enalapril, lisinopril, ramipril), particularly if you have kidney problems related to diabetes.
• Aliskirén.

Your doctor may monitor your kidney function, blood pressure, and electrolyte levels in the blood (for example, potassium) at regular intervals.

See also the information under the heading “Do not take Olmesartan medoxomilo/Amlodipino Pensa”.

Tell your doctorif you have any of the following health problems:

• Kidney problems or a kidney transplant.
• Liver disease.
• Heart failure or problems with heart valves or heart muscle.
• Severe vomiting, diarrhea, treatment with high doses of medications that increase urine production (diuretics), or if you are on a low-sodium diet.
• Elevated potassium levels in the blood.
• Problems with the adrenal glands (glands that produce hormones located above the kidneys).

Contact your doctor if you experience severe, persistent diarrhea, and significant weight loss. Your doctor will evaluate your symptoms and decide how to continue your blood pressure treatment.

Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking Olmesartan /Amlodipino Pensa. Your doctor will decide whether to continue treatment. Do not stop taking Olmesartan /Amlodipino Pensa on your own.

Like any other medication that lowers blood pressure, excessive lowering of blood pressure in patients with alterations in blood flow to the heart or brain can cause a heart attack or stroke. Therefore, your doctor will carefully monitor your blood pressure.

Inform your doctor if you are pregnant or think you may be pregnant. Olmesartan medoxomilo/Amlodipino Pensa is not recommended for use at the beginning of pregnancy, and it should not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if taken during this period (see section “Pregnancy and breastfeeding”).

Children and adolescents (under 18 years)

Olmesartan medoxomilo/Amlodipino Pensa is not recommended for children and adolescents under 18 years.

Use of Olmesartan /Amlodipino Pensa with other medications

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any of the following medications:

• Other blood pressure-lowering medications,as they may increase the effect of Olmesartan /Amlodipino Pensa.

Your doctor may need to adjust your dose and/or take other precautions:

If you are taking an ACE inhibitor or aliskirén (see also the information under the headings “Do not take Olmesartan medoxomilo/Amlodipino Pensa” and “Warnings and precautions”).

• Potassium supplements, salt substitutes containing potassium, medications that increase urine production(diuretics), orheparin(to thin the blood and prevent blood clots). The use of these medications at the same time as Olmesartan medoxomilo/Amlodipino Pensa may elevate potassium levels in the blood.
• Thelithium(medication used to treat mood changes and some types of depression) used at the same time as Olmesartan medoxomilo/Amlodipino Pensa may increase its toxicity. If you need to take lithium, your doctor will measure lithium levels in the blood.
• Thenonsteroidal anti-inflammatory drugs(NSAIDs, medications used to relieve pain, swelling, and other symptoms of inflammation, including arthritis) used at the same time as Olmesartan medoxomilo/Amlodipino Pensa may increase the risk of kidney failure. The effect of Olmesartan medoxomilo/Amlodipino Pensa may be reduced by NSAIDs.
• Colesevelam hydrochloride,a medication that lowers cholesterol levels in the blood, as it may reduce the effect of Olmesartan medoxomilo/Amlodipino Pensa. Your doctor may advise you to take Olmesartan medoxomilo/Amlodipino Pensa at least 4 hours before colesevelam hydrochloride.
• Certain antacids(remedies for indigestion and heartburn), as they may slightly reduce the effect of Olmesartan medoxomilo/Amlodipino Pensa.
• Medications used to treat HIV/AIDS(e.g. ritonavir, indinavir, nelfinavir)or fungal infections(e.g. ketoconazole, itraconazole).
• Diltiazem, verapamil (medications used to treat heart rhythm problems and high blood pressure).
• Rifampicin, erythromycin, clarithromycin(antibiotics).
• St. John's Wort(Hypericum perforatum), herbal remedy.
• Dantrolene(in infusion for severe body temperature abnormalities).
• Simvastatin, a medication used to lower cholesterol and triglyceride levels in the blood.
• Tacrolimus, cyclosporine,used to control the body's immune response, makingit possible for the body to accept the transplanted organ.

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.

Taking Olmesartan Amlodipino Pensa with food and drinks

Olmesartan /Amlodipino Pensa can be taken with or without food. Take the tablets with a little liquid (such as a glass of water). If possible, take the daily dose at the same time each day, for example, at breakfast time.

People taking Olmesartan /Amlodipino Pensa should not consume grapefruit or grapefruit juice. This is because grapefruit and grapefruit juice may lead to an increase in the blood levels of the active ingredient amlodipino, which may cause an unpredictable increase in the blood pressure-lowering effect of Olmesartan /Amlodipino Pensa.

Older patients

If you are over 65 years old, your doctor will regularly monitor your blood pressure each time you increase the dose, to ensure that it does not drop too low.

Black patients

Like other similar medications, the blood pressure-lowering effect of Olmesartan /Amlodipino Pensa is somewhat less in black patients.

Pregnancy and breastfeeding

Pregnancy

Inform your doctor if you are pregnant, or if you think you may be pregnant.

Your doctor will advise you to stop taking Olmesartan /Amlodipino Pensa before becoming pregnant or as soon as you know you are pregnant, and will advise you to take another medication instead of Olmesartan /Amlodipino Pensa. Olmesartan /Amlodipino Pensa is not recommended for use at the beginning of pregnancy, and it should not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used during this period.

If you become pregnant while taking Olmesartan /Amlodipino Pensa, inform and visit your doctor immediately.

Breastfeeding

Inform your doctor if you are breastfeeding or plan to startbreastfeeding. Olmesartan /Amlodipino Pensa is not recommended for mothers who are breastfeeding, and your doctor may choose another treatment if you wish to breastfeed, especially if your baby is newborn or premature.

It has been shown that amlodipinopasses into breast milkin small amounts. If you are breastfeeding, or are about to start, you must inform your doctor before takingOlmesartán /Amlodipino Pensa.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Driving and operating machines

During blood pressure treatment, you may experience drowsiness, feel sick, or dizzy, or have a headache. If this occurs, do not drive or operate machines until the symptoms have disappeared. Consult your doctor.

Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

• The recommended dose of Olmesartan / Amlodipino Pensa is one tablet per day.
• The tablets can be taken with or without food. Take the tablets with a little liquid (such as a glass of water). Do not chew the tablet. Do not take Olmesartan / Amlodipino Pensa with grapefruit juice.
• Try to take your daily dose at the same time each day, for example at breakfast time.

If you take more Olmesartan / Amlodipino Pensa than you should

If you take more tablets than you should, you will probably experience a drop in blood pressure, accompanied by symptoms such as dizziness, and a rapid or slow heart rate.

Excess fluid may accumulate in the lungs (pulmonary edema) causing difficulty breathing that may develop up to 24-48 hours after ingestion.

If you take more tablets than you should or a child accidentally ingests some tablets, contact your doctor immediately or go to the nearest emergency center and bring the medication packaging or this leaflet with you.

In case of overdose or accidental ingestion, consult the Toxicological Information Service. Phone 91 562 04 20.

If you forget to take Olmesartan / Amlodipino Pensa

If you forget to take a dose, take the usual dose the next day.Do not take a double dose to make up for the missed doses.

If you interrupt treatment with Olmesartan / Amlodipino Pensa

It is essential to continue taking Olmesartan / Amlodipino Pensa, unless your doctor tells you to stop treatment.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Like all medicines, this medicine can cause side effects, although not everyone will experience them. If they occur, they are often mild and do not require interrupting treatment.

The following side effects can be serious, although they may affect only a small group of people:

During treatment with Olmesartan medoxomilo/Amlodipino Pensa, allergic reactions can occur, which can affect the entire body, with inflammation of the face, mouth, and/or larynx (vocal cords), along with itching and skin rash.If this happens, stop taking Olmesartan/Amlodipino Pensa and consult your doctor immediately.

Olmesartan medoxomilo/Amlodipino Pensa can cause a pronounced drop in blood pressure in susceptible patients, or as a result of an allergic reaction. This can cause dizziness or severe drowsiness.If this happens, stop taking Olmesartan/Amlodipino Pensa, consult your doctor immediately, and remain lying down in a horizontal position.

Unknown frequency: If you experience yellowing of the whites of the eyes, dark urine, itching of the skin, even if you started treatment withOlmesartán/Amlodipino Pensasome time ago,contact your doctor immediatelywho will evaluate your symptoms and decide how to continue treatment for high blood pressure.

Other possible side effects with Olmesartan/Amlodipino Pensa:

Frequent (can affect up to 1 in 10 people):

Dizziness; headache; swelling of the ankles, feet, legs, hands, or arms; fatigue.

Less frequent (can affect up to 1 in 100 people):

Dizziness when standing up; lack of energy; numbness or tingling in the hands or feet; vertigo; feeling the heartbeat; rapid heartbeat; low blood pressure with symptoms such as dizziness, drowsiness; difficulty breathing; cough; nausea; vomiting; indigestion; diarrhea; constipation; dry mouth; abdominal pain; skin rash; muscle cramps; pain in the arms and legs; back pain; sensation of urgency to urinate; sexual inactivity; inability to achieve or maintain an erection; weakness.

Also, some changes in the results of certain blood tests have been observed:

Increased, as well as decreased, levels of potassium in the blood, increased levels of creatinine in the blood, increased levels of uric acid, increased values of liver function tests (levels of gamma-glutamyl transferase).

Rare (can affect up to 1 in 1,000 people):

Medication hypersensitivity; fainting; flushing and sensation of heat in the face; red itchy rash (urticaria); facial inflammation.

Intestinal angioedema: swelling in the intestine with symptoms such as abdominal pain, nausea, vomiting, and diarrhea.

Side effects reported with the use of olmesartan medoxomilo or amlodipino alone, but not with Olmesartan/Amlodipino Pensa, or with a higher frequency:

Olmesartán

Frequent (can affect up to 1 in 10 people):

Bronchitis; sore throat; congestion and nasal secretion; cough; abdominal pain; viral gastroenteritis; diarrhea; indigestion; nausea; joint and bone pain; back pain; blood in the urine; urinary tract infection; chest pain; flu-like symptoms; pain. Changes in the results of blood tests, such as increased levels of a type of fat (hypertriglyceridemia); increased uric acid and urea in the blood, and increased values of liver and muscle function tests.

Less frequent (can affect up to 1 in 100 people):

Reduction in the number of a type of blood cell, called platelets, which can cause easy bruising or prolong bleeding time; rapid allergic reactions, which can affect the entire body and cause respiratory problems, as well as rapid drop in blood pressure, which can even cause fainting (anaphylactic reactions);angina (painorsensation ofdiscomfortin thechest,knownasangina pectoris); itching;skin rash;allergic skin rash;urticaria;facial swelling;muscle pain;discomfort.

Rare (can affect up to 1 in 1,000 people):

Facial, mouth, and/or laryngeal (vocal cord) inflammation; acute renal failure and renal insufficiency;lethargy.

Amlodipino

Very frequent (can affect more than 1 in 10 people):

Edema (fluid retention).

Frequent (can affect up to 1 in 10 people):

Abdominal pain; nausea; swelling of the ankles; drowsiness; flushing and sensation of heat in the face, visual disturbances (including double vision and blurred vision), feeling the heartbeat, diarrhea, constipation, indigestion, muscle cramps, weakness, difficulty breathing.

Less frequent (can affect up to 1 in 100 people):

Difficulty sleeping; sleep disorders; mood changes, including anxiety;depression;irritability;shakiness;alterations in taste; fainting;ringing in the ears(tinnitus);emergenceofangina pectoris(painorsensation ofdiscomfortin thechest); irregular heartbeat;nasal secretion or congestion; hair loss;purple spotsor skin spotsdue to small hemorrhages(purpura);skin discoloration;excessive sweating;skin rash; itching; red itchy rash (urticaria);joint or muscle pain;urination problems;urgency to urinate at night;increased need to urinate,enlargement of the breastsin men,chest pain;pain; feeling ofdiscomfort;weight gain or loss.

Rare (can affect up to 1 in 1,000 people):

Confusion.

Very rare (can affect up to 1 in 10,000 people):

Reduction in the number of white blood cells, which could increase the risk of infections; reduction in the number of a type of blood cell called platelets, which could cause the appearance of bruises and prolong bleeding time; increased blood glucose; increased muscle tension or increased resistance to passive movement (hypertonia);numbness or tingling in the hands or feet; heart attack; inflammation of the blood vessels; inflammation of the liver or pancreas; inflammation of the stomach wall; gum thickening; elevated liver enzymes; yellow skin and eyes; increased skin sensitivity to light; severe allergic reactions, itching, rash, facial, mouth, and/or laryngeal (vocal cord) inflammation, along with itching and rash, severe skin reactions, including intense skin rash, urticaria, facial flushing, severe itching, blisters, peeling, and inflammation of the skin, severe inflammation of the mucous membranes sometimes very severe.

Unknown frequency (cannot be estimated from available data):

Toxic epidermal necrolysis.

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the packaging (after “CAD.:”). The expiration date is the last day of the month indicated.

No special storage conditions are required.

Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.

Composition ofOlmesartán/AmlodipinoPensa

The active principles are olmesartan medoxomil and amlodipine (as besilate).

Each tablet contains 40 mg of olmesartan medoxomil and 10 mg of amlodipine (as besilate).

The other components are:

Tablet core: Pregelatinized cornstarch, sodium croscarmellose, microcrystalline cellulose, and magnesium stearate.

Tablet coating: Opadry Y-1-7000 and Red Iron Oxide (E172).

Appearance of the product and content of the packaging

Brown-red, cylindrical, scored tablet with a film coating, with the inscription “OA1” on the other side.

The score is only for breaking and facilitating swallowing, but not for dividing into equal doses.

Olmesartán/AmlodipinoPensais presented in packaging containing 28 tablets.

Holder of the marketing authorization and responsible for manufacturing

Holder of the marketing authorization:

Towa Pharmaceutical, S.A.

C/ de Sant Martí, 75-97

08107 Martorelles (Barcelona)

Spain

Responsible for manufacturing:

Laboratorios Cinfa, S.A.

Ctra. Olaz-Chipi, 10, Pol. Ind. Areta, Huarte, 31620 Navarra

Spain

Date of the last review of this leaflet:February 2025

The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.